Alan Bell

Alan Bell is a Global Clinical Development Director specializing in Respiratory and Immunology with extensive experience in the pharma, biotech, and CRO industries. They have a strong background in drug development and clinical trial design, particularly in Respiratory and Infectious Disease, supported by a postgraduate education focused on respiratory medicine and clinical pharmacology. Alan's recent role was as a Global Clinical Development Scientist at AstraZeneca, where they contributed to late-stage clinical programs. Throughout their career, they have held various positions, including Director of Clinical Development and Operations at Poolbeg Pharma and Director of Translational Operations at hVIVO, showcasing their expertise and leadership in the field.